Macrophage-mediated delivery of siEphA2 lipid nanoparticles and Abraxane reduces tumor burden: 3D co-culture, in vivo assessment and mathematical modelling evaluation of breast cancer liver metastasis
273.5%), indicating effective siRNA delivery and target suppression. A mathematical model incorporating macrophage-mediated siEphA2-LNP transport, with or without nab-PTX, was developed to evaluate treatment schedules under varying tumor microenvironment conditions. Collectively, these findings highlight the potential for tailoring macrophage-mediated EphA2-siRNA-LNP therapy for BCLM based on patient-specific tumor characteristics.
Authors
- Biana Godin (ORCID: https://orcid.org/0000-0001-6089-6695)
- Anjana Tiwari (ORCID: https://orcid.org/0009-0000-6724-2774)
- LaMargaret Temukisa Johnson
- Dylan Goodin (ORCID: https://orcid.org/0000-0001-9072-7411)
- Arvind Pandey
- Jenna Grace Carr
- Eric Chau
- Thy Nguyen (ORCID: https://orcid.org/0009-0002-2736-6806)
- Hermann Frieboes
Institutions
- Houston Methodist (US)
- University of Louisville (US)
- Methodist Hospital (US)
- Houston Methodist Research Institute (US)
- Texas A&M University (US)
Publication Details
- Journal
- Nanoscale
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1039/d6nr03588d
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Prevention and Research Institute of Texas
- DOD Peer Reviewed Cancer Research Program